dataset from the mutant crystal was collected at 100 K at BL41XU of SPring-8
(wavelength, 1.00000 Å), by using an ADSC Quantum 210 CCD detector. All
data were indexed, integrated, and scaled with the HKL2000 program (19).
The initial phases of the wild-type apo structure were determined by
molecular replacement by using the BAS structure model generated by
structure of M. sativa CHS [Protein Data Bank (PDB) entry 1BQ6], as a search
model. The molecular replacement was performed with the program Crystal-
lography and NMR System (CNS) (20). Crystallographic refinement and model
building were performed with CNS and XTALVIEW (21), respectively. Each re-
finement cycle was followed by model building using the σA-weighted 2Fo-Fc
and Fo-Fc electron density maps. The water molecules were automatically
placed into the difference electron density maps with XTALVIEW, and were
retained or rejected on the basis of geometric criteria as well as their refined
B-factors. After several rounds of model building and refinement, the final
model was obtained. The other structures were solved by the same procedure
as used for the model refinement of the BAS wild-type apo structure, except
for the use of either the entire or I204L/L208F-substituted final models of the
wild-type apo structure as the search model in the molecular replacement
methods. Both the 2Fo-Fc and Fo-Fc maps indicated the presence of a portion
of the monoketide intermediate covalently bound to the catalytic cysteine of
each monomer in the intermediate-complexed structure, and the intermedi-
ate manually fits into the visible electron density. Each model consists of re-
sides 8–383 of monomer A, and residues 8–382 of monomer B. The qualities
of the final models were assessed with PROCHECK (22). Details of the data
collection, processing, and structure refinement are summarized in Table S1.
The cavity volume and the active-site entrance area were calculated by the
volume of 500 μL of 100 mM Tris-HCl buffer (pH 8.0) and 1 mM EDTA. Incuba-
tions were performed at 30 °C for 1 hr, and were stopped by the addition of
50 μL of 20% HCl. The products were then extracted with 3 mL of ethyl
acetate. The products were separated by reverse-phase HPLC (JASCO 880)
on a TSK-gel ODS-80Ts column (4.6 ÅE 150 mm, TOSOH), at a flow rate of
0.8 mL∕ min. Gradient elution was performed with H2O and MeOH, both
containing 0.1% TFA: 0–5 min, 30% MeOH; 5–17 min, linear gradient from
30 to 60% MeOH; 17–25 min, 60% MeOH; 25–27 min, linear gradient from 60
to 70% MeOH. Elutions were monitored by a multichannel UV detector
(MULTI 340, JASCO) at 280 nm. UV spectra (198–400 nm) were recorded every
0.4 s. Online LC-ESIMS spectra were measured with an Agilent Technologies
series 1100 HPLC coupled to a Bruker Daltonics esquire4000 ion-trap mass
spectrometer fitted with an ESI source. HPLC separations were performed
under the same conditions as described above. The ESI capillary temperature
and the capillary voltage were 320 °C and 4.0 V, respectively. The tube lens
offset was set at 20.0 V. All spectra were obtained in the positive mode over a
mass range of m∕z 50–500, and at a range of one scan every 0.2 s. The
collision gas was helium, and the relative collision energy scale was set at
30.0% (1.5 eV).
Spectroscopic Data for (E)-5-(4-Hydroxyphenyl)-3-Oxopent-4-Enoic Acid
(4-Coumaroyl Diketide β-Keto Acid). UV λmax 283 nm; LC-ESIMS: MS, m∕z 207
½M þ Hꢀþ, MS/MS (precursor ion at m∕z 207), m∕z 147 ½M þ H-CO2-CH2ꢀþ; HRMS
(FAB) found for ½C11H11O4ꢀþ 207.0668, calculated value 207.0657.
ACKNOWLEDGMENTS. This work was supported in part by a Grant-in-Aid for
Scientific Research from the Ministry of Education, Culture, Sports, Science
and Technology, Japan (I.A. and H.M.), by grants from The Naito Foundation
(I.A.) and Takeda Science Foundation (H.M.), and from the National Project
on Protein Structural and Functional Analyses (S.S. and T.K.).
Enzyme Reaction. The reaction mixture contained 54 μM of 4-coumaroyl-CoA,
108 μM of malonyl-CoA, and 20 μg of the purified wild-type enzyme in a final
1. Schröder J (1999) Comprehensive Natural Products Chemistry, (Elsevier, Oxford), Vol 1,
pp 749–771.
12. Rubin-Pitel SB, et al. (2008) Distinct structural elements dictate the specificity of the
type III pentaketide synthase from Neurospora crassa. Chem Biol, 15:1079–1090.
2. Austin MB, Noel JP (2003) The chalcone synthase superfamily of type III polyketide
synthases. Nat Prod Rep, 20:79–110.
3. Morita H, Abe I, Noguchi H (2009) Comprehensive Natural Products Chemistry (Elsevier,
Oxford, in press).
4. Abe I, Takahashi Y, Morita H, Noguchi H (2001) Benzalacetone synthase. A novel
polyketide synthase that plays a crucial role in the biosynthesis of phenylbutanones
in Rheum palmatum. Eur J Biochem, 268:3354–3359.
5. Ferrer JL, Jez JM, Bowman ME, Dixon RA, Noel JP (1999) Structure of chalcone synthase
and the molecular basis of plant polyketide biosynthesis. Nat Struct Biol, 6:775–784.
6. Jez JM, et al. (2000) Structural control of polyketide formation in plant-specific
polyketide synthases. Chem Biol, 7:919–930.
13. Abe I, Sano Y, Takahashi Y, Noguchi
H (2003) Site-directed mutagenesis of
benzalacetone synthase. The role of the Phe215 in plant type III polyketide synthases.
J Biol Chem, 278:25218–25226.
14. Abe T, et al. (2007) Structure function analysis of benzalacetone synthase from Rheum
palmatum. Bioorg Med Chem Lett, 17:3161–3166.
15. Jez JM, Bowman ME, Noel JP (2002) Expanding the biosynthetic repertoire of plant
type III polyketide synthases by altering starter molecule specificity. Proc Natl Acad
Sci USA, 99:5319–5324.
16. Abe I, Abe T, Wanibuchi K, Noguchi H (2006) Enzymatic formation of quinolone
alkaloids by a plant type III polyketide synthase. Org Lett, 8:6063–6065.
17. Funa N, Awakawa T, Horinouchi S (2007) Pentaketide resorcylic acid synthesis by type
III polyketide synthase from Neurospora crassa. J Biol Chem, 282:14476–14481.
18. Morita H, et al. (2008) Crystallization and preliminary crystallographic analysis of a
plant type III polyketide synthase that produces benzalacetone. Acta Crystallogr Sect
F Struct Biol Cryst Commun, 64:304–306.
19. Otwinowski Z, Minor W (1997) Processing of x-ray diffraction data collected in oscilla-
tion mode. Methods Enzymol, 276:307–326.
20. Brunger AT, et al. (1998) Crystallography & NMR system: A new software suite for
macromolecular structure determination. Acta Crystallogr
54:905–921.
21. McRee DE (1992) A visual protein crystallographic software system for X11/Xview. J
Mol Graphics Modell, 10:44–46.
7. Austin MB, Bowman ME, Ferrer JL, Schröder J, Noel JP (2004) An aldol switch dis-
covered in stilbene synthases mediates cyclization specificity of type III polyketide
synthases. Chem Biol, 11:1179–1164.
8. Austin MB, et al. (2004) Crystal structure of a bacterial type III polyketide synthase and
enzymatic control of reactive polyketide intermediates.
J
Biol Chem,
279:45162–45174.
9. Sankaranarayanan R, et al. (2004) A novel tunnel in mycobacterial type III polyketide
synthase reveals the structural basis for generating diverse metabolites. Nat Struct Mol
Biol, 11:894–900.
10. Morita H, et al. (2007) Structural insight into chain-length control and product
specificity of pentaketide chromone synthase from Aloe arborescens. Chem Biol,
14:359–369.
D Biol Crystallogr,
22. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to
check the stereochemical quality of protein structures. J Appl Crystallogr, 26:283–291.
11. Goyal A, et al. (2008) Structural insights into biosynthesis of resorcinolic lipids by a type
III polyketide synthase in Neurospora crassa. J Struct Biol, 162:411–421.
Morita et al.
PNAS
∣
January 12, 2010
∣
vol. 107
∣
no. 2
∣
673